IPO-38 Antibodies

Santa Cruz Biotechnology features a diverse variety of IPO-38 monoclonal antibodies for advanced research in cellular biology. IPO-38 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IPO-38, implicated in cell cycle regulation and apoptosis, plays a vital role in maintaining cellular homeostasis and responding to stress signals. IPO-38 dysregulation has been associated with various diseases, including cancer, making it a significant target for therapeutic intervention and biomarker discovery. Understanding IPO-38 function is essential for elucidating the mechanisms underlying cell proliferation and survival. Researchers worldwide rely on IPO-38 monoclonal antibodies to advance their studies in cell biology and disease mechanisms. Current investigations focus on how IPO-38 influences cellular pathways and its potential as a therapeutic target. IPO-38 monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to scientific understanding of cellular processes and disease development.